{"id":"W4392797262","doi":"10.1016/j.ijrobp.2024.01.075","title":"A Phase 2 Clinical Trial of Pembrolizumab with Radiation Following Progression on anti-PD-1 Therapy in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck","year":2024,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Pembrolizumab; Oncology; Head and neck; Radiation therapy; Internal medicine; Basal cell; Head and neck squamous-cell carcinoma; Head and neck cancer; Radiology; Surgery; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001655045,0.00164646,0.00239188,0.0005068154,0.000559058,0.00112074,0.001032448,0.001555855,0.003578301],"category_scores_gemma":[0.001027867,0.00060468,0.001859015,0.0004072186,0.001209742,0.001238573,0.0004285554,0.004521359,0.0007789262],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001237661,"about_ca_system_score_gemma":0.001737306,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001817835,"about_ca_topic_score_gemma":0.004863303,"domain_scores_codex":[0.9995757,0.0001718609,0.00001550382,0.00008255534,0.00002725933,0.0001270776],"domain_scores_gemma":[0.9994475,0.00009541514,0.00008022785,0.000047543,0.00002743957,0.0003018999],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7917247,0.08057536,0.004764594,0.000692467,0.001331037,0.0002668237,0.000458722,0.002777229,0.02646561,0.0003131283,0.003264995,0.08736521],"study_design_scores_gemma":[0.5777957,0.4074643,0.009427484,0.00003305986,0.0004136455,0.0001568065,0.00008287566,0.001017679,0.001744402,0.0001755959,0.001661566,0.00002688788],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943753,0.001211198,0.0002220526,0.0004887414,0.0001709073,0.001660942,0.0004549205,0.00004653556,0.001369303],"genre_scores_gemma":[0.9911159,0.001357174,0.0009999229,0.000684726,0.000194617,0.0024569,0.001233739,0.00002005716,0.001936973],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003578301,"threshold_uncertainty_score":0.01197064,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03808368005064678,"score_gpt":0.3983998450904633,"score_spread":0.3603161650398166,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}